| Net income | 44.93M |
| (Increase) decrease in fair value of derivative instruments | |
| Depreciation and amortization | 27.78M |
| Loss on redemption of debt | 0 |
| Provision for losses on accounts receivable | |
| Change in deferred taxes | 9.67M |
| Increase in receivables | 10.97M |
| Increase in inventories | 9.98M |
| Increase in other assets | -2.35M |
| Increase in accounts payable | -705K |
| Decrease in customer credit balances | 6.49M |
| Increase in other current and long-term liabilities | |
| Net cash used in operating activities | |
| Capital expenditures | -10.13M |
| Proceeds from sales of fixed assets | 318K |
| Acquisitions | -9.82M |
| Net cash used in investing activities | |
| Revolving credit facility borrowings | 0 |
| Repayment of debt | -7.5M |
| Proceeds from the issuance of debt | |
| Debt extinguishment costs | 0 |
| Distributions | -23.09M |
| Unit repurchase | |
| Deferred charges | |
| Net cash provided by financing activities | |
| Net decrease in cash and cash equivalents | 38.68M |
| Cash and cash equivalents at beginning of period | 100.51M |
| Cash and cash equivalents at end of period | 139.19M |